CDKN2A and nasopharyngeal carcinoma: Among these genes, the inactivation of p16/CDKN2A by homozygous deletion and promoter hypermethylation has been consistently found in almost all NPC samples examined [67], suggesting that the expression of the p16 gene product is commonly downregulated in NPC.